Correlation Between Shuttle Pharmaceuticals and Pacira BioSciences,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and Pacira BioSciences,, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and Pacira BioSciences,.

Diversification Opportunities for Shuttle Pharmaceuticals and Pacira BioSciences,

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Shuttle and Pacira is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Shuttle Pharmaceuticals and Pacira BioSciences,

Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to under-perform the Pacira BioSciences,. In addition to that, Shuttle Pharmaceuticals is 4.85 times more volatile than Pacira BioSciences,. It trades about -0.17 of its total potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.05 per unit of volatility. If you would invest  1,713  in Pacira BioSciences, on August 27, 2024 and sell it today you would earn a total of  29.00  from holding Pacira BioSciences, or generate 1.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shuttle Pharmaceuticals  vs.  Pacira BioSciences,

 Performance 
       Timeline  
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Pacira BioSciences, 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Shuttle Pharmaceuticals and Pacira BioSciences, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shuttle Pharmaceuticals and Pacira BioSciences,

The main advantage of trading using opposite Shuttle Pharmaceuticals and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.
The idea behind Shuttle Pharmaceuticals and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account